Kidney and liver involvement in cryoglobulinemia

Seminars in Nephrology

Volumn 22, Issue 4, 2002, Pages 309-318

  Fabrizi, Fabrizio ^a,b   Colucci, Patrizia ^a,b   Ponticelli, Claudio ^a,b   Locatelli, Francesco ^a,b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b A MANZONI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN M; RIBAVIRIN; STEROID;

CRYOGLOBULINEMIA; HEPATITIS C; HUMAN; IMMUNOPATHOGENESIS; KIDNEY DISEASE; LIVER DISEASE; PATHOPHYSIOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; CRYOGLOBULINEMIA; HEPATITIS C; HUMANS; INTERFERON-ALPHA; KIDNEY DISEASES; LIVER DISEASES;

EID: 0036073224     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Hyperproteinemia associated with multiple myeloma: With report of a case in which an extraordinary hyperproteinemia was associated with thrombosis of the retinal veins and symptoms suggesting Raynaud's disease
2. Studies of cryoglobulins. I. Unusual purpura associated with the presence of a high concentration of cryoglobulin (cold precipitable serum globulin)
3. Cryoglobulinemia, a clinical and laboratory study
4. Cryoglobulins III: Further studies on the nature, incidence, clinical, diagnostic, prognostic and immunopathologic significance of cryoproteins in renal disease
5. Biological and clinical significance of cryoglobulins. A report of 86 cases
6. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia
7. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia
8. Antibodies to hepatitis C virus in essential mixed cryoglobulinemia
9. Mixed cryoglobulinemia and hepatitis C virus
10. A role for hepatitis C virus infection in type II cryoglobulinemia
11. High prevalence of hepatitis C virus RNA in the supernatant and the cryoprecipitate of patients with essential and secondary type II mixed cryoglobulinemia
12. Cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus
13. Hepatitis C virus infection and acute or chronic glomerulonephritis: An epidemiological and clinical appraisal
14. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection
15. Mixed cryoglobulinemia: Clinical aspects and long-term follow-up of 40 patients
16. Secondary and essential cryoglobulinemias. Frequency, nosological classification and long-term follow-up
17. Renal disease in essential mixed cryoglobulinemia: Long-term follow-up of 44 patients
18. Extrahepatic manifestations associated with hepatitis C virus infection
19. Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection
20. Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinemia in hepatitis C virus patients: A prospective study
21. Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis
22. Identification of glomerular immune deposits in cryoglobulinemia glomerulonephritis
23. The relationship of infiltrating renal leucocytes to disease activity in lupus and cryoglobulinemic glomerulonephritis
24. Cell interposition in glomerular capillary walls in cryoglobulinemic glomerulonephritis. Ultrastructural investigation of 23 cases
25. Thrombotic microangiopathy associated with cryoglobulinemic membranoproliferative glomerulonephritis and hepatitis C
26. Anticardiolipin antibodies in chronic hepatitis C: Implication of hepatitis C as the cause of the antiphospholipid syndrome
27. Increased rate of thrombin generation in hepatitis C virus cirrhotic patients: Relationship to venous thrombosis
28. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis
29. Peripheral nervous system involvement in essential cryoglobulinemia and nephropathy
30. Intestinal vasculitis in essential, mixed cryoglobulinemia
31. Lung function in essential mixed cryoglobulinemia: A short-term follow-up
32. Cryoglobulinemic glomerulonephritis: A membranoproliferative glomerulonephritis induced by hepatitis C virus
33. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis
34. Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or mixed III mixed cryoglobulinemia
35. Glomerulonephritis induced by human IgMκ-IgG cryoglobulins in mice
36. High binding of immunoglobulin Mk rheumatoid factor from type II cryoglobulins to cellular fibronectin: A mechanism for induction of in situ immune complex glomerulonephritis?
37. Glomerulonephritis associated with hepatitis C virus infection
38. Liver involvement in the syndrome of mixed cryoglobulinemia
39. Lung involvement in essential mixed cryoglobulinemia
40. Renal disease in 18 patients with mixed type 11 IgM-IgG cryoglobulinemia: Monoclonal lymphoid infiltration (2 cases) and membranoproliferative glomerulonephritis (14 cases)
41. A long-term follow-up study in essential cryoglobulinemia
42. Long-term results of therapy with interferon-α for type 11 essential mixed cryoglobulinemia
43. The cryoglobulins: An overview
44. Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage
45. Cryoglobulinemia in chronic hepatitis C virus infection: Prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates
46. Interferon alpha in mixed cryoglobulinemia patients: A randomized, cross-over-controlled trial
47. Complete remission of cryoglobulinemic glomerulonephritis (HCV-positive) after high dose interferon therapy
48. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus
49. Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interpheron-alpha
50. Treatment of HCV related liver disease in the dialysis population: A novel challenge for clinical nephrologists
51. Treatment of idiopathic mixed cryoglobulinemic with alpha interferon
52. Natural interferon-α versus its combination with 6-methyl-prednisolone in the therapy of type 11 mixed cryoglobulinemia: A long-term, randomized, controlled study
53. Hepatitis C virus-associated glomerulonephritis. Effects of α-interferon therapy
54. Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-α and ribavirin
55. Successful cyclophosphamide treatment of cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection
56. Effect of human leukocyte alpha interferon on cryoglobulinaemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection
57. Response to high-dose interferon-α after failure of standard therapy in MPGN associated with hepatitis C virus infection
58. Hepatitis C-associated glomerulonephritis-a novel therapeutic approach
59. Membranoproliferative glomerulonephritis and hepatitis C: Effects of interferon-α therapy on clinical outcome and histological pattern
60. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection responsive to interferon-α
61. Spontaneous remission of HCV-induced cryoglobulinaemic glomerulonephritis